Intracoronary melatonin increases coronary blood flow and cardiac function through β-adrenoreceptors, MT1/MT2 receptors, and nitric oxide in anesthetized pigs

Journal of Pineal Research

Volumn 51, Issue 2, 2011, Pages 246-257

  Grossini, Elena ^a   Molinari, Claudio ^a   Uberti, Francesca ^a   Mary, David A S G ^a   Vacca, Giovanni ^a   Caimmi, Philippe P ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

autonomic nervous system; cardiac contractility; melatonin; nitric oxide; vasodilation

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ATENOLOL; ATROPINE; BETA ADRENERGIC RECEPTOR; BUTOXAMINE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MUSCARINIC RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENTOLAMINE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ENZYME INHIBITION; HEART FUNCTION; HEART MUSCLE PERFUSION; HEART OUTPUT; HEART PROTECTION; HEART RATE; HEMODYNAMIC PARAMETERS; IN VIVO STUDY; NONHUMAN;

ANESTHESIA; ANIMALS; ANTIOXIDANTS; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; HEART RATE; MELATONIN; MUSCLE PROTEINS; NITRIC OXIDE; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; RECEPTORS, ADRENERGIC, BETA; SWINE;

EID: 80051665469     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00886.x     Document Type: Article

References (62)

1. Cagnacci A,. Melatonin in relation to physiology in adult humans. J Pineal Res 1996; 21: 200-213. (Pubitemid 126733136)
2. Reiter RJ,. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151-180.
3. Važan R, Styk J, Béder I, Pancza D,. Effect of melatonin on the isolated heart in the standard perfusion conditions and in the conditions of calcium paradox. Gen Physiol Biophys 2003; 22: 41-50. (Pubitemid 36748379)
4. Arangino S, Cagnacci A, Angiolucci M, et al., Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 1999; 83: 1417-1419. (Pubitemid 29205758)
5. Reiter RJ, Tan DX, Korkmaz A,. The circadian melatonin rhythm and its modulation: possible impact on hypertension. J Hypertens 2009; 27: S17-20.
6. Claustrat B, Brun J, Chazot G,. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005; 9: 11-24. (Pubitemid 40092915)
7. Inui Y, Hazeki O,. Acute effects of melatonin and its time of administration on core body temperature and heart rate in cynomolgus monkeys. J Toxicol Sci 2010; 35: 383-391.
8. Kawashima K, Miwa Y, Fujimoto K, et al., Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin Exp Hypertens A 1987; 9: 1121-1131.
9. Abete P, Bianco S, Calabrese C, et al., Effects of melatonin in isolated rat papillary muscle. FEBS Lett 1997; 412: 79-85. (Pubitemid 27310004)
10. Vazan R, Pancza D, Béder I, et al., Ischemia-reperfusion injury - antiarrhythmic effect of melatonin associated with reduced recovering of contractility. Gen Physiol Biophys 2005; 24: 355-359. (Pubitemid 41723840)
11. Tan DX, Manchester LC, Reiter RJ, Qi W, Kim SJ, El-Sokkary GH,. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 1998; 25: 184-191. (Pubitemid 28430599)
12. Chen Z, Chua CC, Gao J, et al., Prevention of ischemia/reperfusion- induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxidase 1. J Pineal Res 2009; 46: 235-241.
13. Genade S, Genis A, Ytrehus K, et al., Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. J Pineal Res 2008; 45: 449-458.
14. Jonas M, Garfinkel D, Zisapel N, et al., Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press 2003; 12: 19-24. (Pubitemid 36416949)
15. Girotti L, Lago M, Ianovsky O, et al., Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure. Endocrine 2003; 22: 245-248. (Pubitemid 38183700)
16. Brugger P, Marktl W, Herold M,. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995; 345: 1408.
17. Domínguez-Rodríguez A, Abreu-González P, García MJ, et al., Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 2002; 33: 248-252. (Pubitemid 35252997)
18. Satake N, Oe H, Sawada T, et al., The mode of vasorelaxing action of melatonin in rabbit aorta. Gen Pharmacol 1991; 22: 219-221.
19. Weekley LB,. Effects of melatonin on isolated pulmonary artery and vein: role of the vascular endothelium. Pulm Pharmacol 1993; 6: 149-154. (Pubitemid 23196630)
20. Girouard H, Chulak C, Lejossec M, et al., Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats. J Hypertens 2001; 19: 1369-1377. (Pubitemid 32730453)
21. Thakor AS, Herrera EA, Seron-FERRE MS, et al., Melatonin and vitamin C increase umbilical blood flow via nitric oxide-dependent mechanisms. J Pineal Res 2010; 49: 399-406.
22. Weekley LB,. Effects of melatonin on pulmonary and coronary vessels are exerted through perivascular nerves. Clin Auton Res 1993; 3: 45-47. (Pubitemid 23136542)
23. Yang Q, Scalbert E, Delagrange P, et al., Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries. Am J Physiol Heart Circ Physiol 2001; 280: H76-H82.
24. Tunstall RR, Shukla P, Grazul-Bilska A, et al., MT2-Receptors Mediate the Inhibitory Effects of Melatonin on Nitric Oxide-Induced Relaxation of Porcine Isolated Coronary Arteries. J Pharmacol Exp Ther 2011; 336: 127-133.
25. Cook JS, Sauder CL, Ray CA,. Melatonin differentially affects vascular blood flow in humans. Am J Physiol Heart Circ Physiol. 2011; 300: H670-H674.
26. Sahna E, Parlakpinar H, Ozturk F, et al., The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res 2003; 31: 188-193. (Pubitemid 36962027)
27. Nishiyama K, Yasue H, Moriyama Y, et al., Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J 2001; 141: E9.
28. K-Laflamme A, Wu L, Foucart S, et al., Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens 1998; 11: 219-229. (Pubitemid 28137615)
29. Girouard H, Denault C, Chulak C, et al., Treatment by n-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve. Am J Hypertens 2004; 17: 947-954. (Pubitemid 39361668)
30. Ray CA,. Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans. J Physiol 2003; 551: 1043-1048. (Pubitemid 37221094)
31. Simko F, Pechanova O,. Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment J. Pineal Res 2009; 47: 127-133.
32. Ekmekcioglu C, Haslmayer P, Philipp C, et al., Expression of the MT1 melatonin receptor subtype in human coronary arteries. J Recept Signal Transduct Res 2001; 21: 85-91. (Pubitemid 33009908)
33. Ekmekcioglu C, Thalhammer T, Humpeler S, et al., The melatonin receptor subtype MT2 is present in the human cardiovascular system. J Pineal Res 2003; 35: 40-44. (Pubitemid 36819169)
34. Capsoni S, Viswanathan M, De Oliveira AM, et al., Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis. Endocrinology 1994; 135: 373-378. (Pubitemid 24203840)
35. Masana MI, Doolen S, Ersahin C, et al., MT(2) melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 2002; 302: 1295-1302. (Pubitemid 34920255)
36. Anwar MM, Meki AR, Rahma HH,. Inhibitory effects of melatonin on vascular reactivity: possible role of vasoactive mediators. Comp Biochem Physiol C Toxicol Pharmacol 2001; 130: 357-367. (Pubitemid 33043708)
37. Silva CL, Tamura EK, Macedo SM, et al., Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro. Br J Pharmacol 2007; 151: 195-205. (Pubitemid 46763046)
38. Cagnacci A, Arangino S, Angiolucci M, et al., Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy. Clin Endocrinol 2001; 54: 261-266. (Pubitemid 32193529)
39. Linden RJ, Mary DASG,. The preparation and maintenance of anaesthetized animals for the study of cardiovascular function. IN: Techniques in cardiovascular physiology, Linden RJ, ed., Life Sci., vol P3/1, Elsevier Science Publishers, Shannon, Ireland, 1983; p. 1-22.
40. Grossini E, Caimmi P, Molinari C, et al., Intracoronary gastrin 17 increases cardiac perfusion and function through autonomic nervous system, CCK receptors and nitric oxide in anesthetized pigs. J Appl Physiol 2011; 110: 95-108.
41. Grossini E, Molinari C, Mary DA, et al., Intracoronary intermedin 1-47 augments cardiac perfusion and function in anesthetized pigs: role of calcitonin receptors and beta-adrenoreceptor-mediated nitric oxide release. J Appl Physiol 2009; 107: 1037-1050.
42. Waldhauser F, Dietzel M,. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann N Y Acad Sci 1985; 453: 205-214. (Pubitemid 16169260)
43. Molinari C, Grossini E, Mary DA, et al., Prolactin induces regional vasoconstriction through the β2- adrenergic and nitric oxide mechanisms. Endocrinology 2007; 148: 4080-4090. (Pubitemid 47105845)
44. Rezzani R, Rodella LF, Bonomini F, et al., Beneficial effects of melatonin in protecting against cyclosporine A-induced cardiotoxicity are receptor mediated J. Pineal Res 2006; 41: 288-295. (Pubitemid 44337727)
45. Lew MJ, Flanders S,. Mechanisms of melatonin-induced vasoconstriction in the rat tail artery: a paradigm of weak vasoconstriction. Br J Pharmacol 1999; 126: 1408-1418. (Pubitemid 29142072)
46. Geary GG, Krause DN, Duckles SP,. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am J Physiol 1997; 273: H1530-H1536.
47. Weekley LB,. Melatonin-induced relaxation of rat aorta: interaction with adrenergic agonists. J Pineal Res 1991; 11: 28-34.
48. Satake N, Shibata S, Takagi T,. The inhibitory action of melatonin on the contractile response to 5-hydroxytryptamine in various isolated vascular smooth muscles. Gen Pharmacol 1986; 17: 553-558. (Pubitemid 16025987)
49. Feigl EO,. Coronary physiology. Physiol Rev 1983; 63: 1-205. (Pubitemid 13188482)
50. Tune JD, Gorman MW, Feigl EO,. Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 2004; 97: 404-415. (Pubitemid 38802544)
51. Gregory NG, Wotton SB,. Autonomic and non-autonomic control of cardiovascular function in stress-sensitive pigs. J Vet Pharmacol Ther 1981; 4: 183-191.
52. Mcgrowder D, Ragoobirsingh D, Dasgupta T,. Effects of S-nitroso-N-acetyl-penicillamine administration on glucose tolerance and plasma levels of insulin and glucagon in the dog. Nitric Oxide 2001; 5: 402-412. (Pubitemid 32735392)
53. Tamura EK, Silva CLM, Markus RP,. Melatonin inhibits endothelial nitric oxide production in vitro. J Pineal Res 2006; 41: 267-274. (Pubitemid 44337723)
54. Tamura EK, Cecon E, Monteiro AWA, et al., Melatonin inhibits LPS-induced NO production in rat endothelial cells. J Pineal Res 2009; 46: 268-274.
55. Henderson AH,. Endothelium in control. Br Heart J 1991; 65: 116-125.
56. Vacca G, Battaglia A, Grossini E, et al., The effect of 17β-oestradiol on regional blood flow in anaesthetized pigs. J Physiol 1999; 514: 875-884. (Pubitemid 29060331)
57. Jugdutt BI,. Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev 2002; 7: 391-405. (Pubitemid 35396471)
58. Giacomo CG, Antonio M,. Melatonin in cardiac ischemia/reperfusion-induced mitochondrial adaptive changes. Cardiovasc Hematol Disord Drug Targets 2007; 7: 163-169. (Pubitemid 47496573)
59. Razavi HM, Hamilton JA, Feng Q,. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther 2005; 106: 147-162. (Pubitemid 40613056)
60. Dominguez-Rodriguez A, Abreu-Gonzalez P,. Myocardial ischemia-reperfusion injury: possible role of melatonin. World J Cardiol 2010; 2: 233-236.
61. Cagnacci A, Arangino S, Angiolucci M, et al., Influences of melatonin administration on the circulation of women. Am J Physiol Regul Integr Comp Physiol 1998; 274: 335-338.
62. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, et al., Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 2010; 49: 14-22.